首页 › 期刊 › Chinese Medical Journal - Pulmonary and Critical Care Medicine
Chinese Medical Journal - Pulmonary and Critical Care Medicine
出版商:Elsevier · ISSN:2772-5588, 2097-1982 · 类型:journal · 官网:https://www.journals.elsevier.com/chinese-medical-journal-pu...
研究主题:Chronic Obstructive Pulmonary Disease (COPD) Research · Asthma and respiratory diseases · Lung Cancer Treatments and Mutations · Lung Cancer Research Studies · Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
数据覆盖:5 个公开学术数据源交叉核验(crossref、jcr、openalex、scimago、cwts)。
数据来源与实体核验
核心指标
- 影响因子(JCR 2025):7.900
- JCR 分区:Q1(CRITICAL CARE MEDICINE)
- SJR:1.967(Q1),2025 年,China
- CWTS 2025:SNIP 1.736 · IPP 7.018 · 自引率 0.0%
- h-index:20
- i10 指数:47
- 近两年篇均被引:8.08
- 载文量 119 · 总被引 1251
- Crossref DOI 总量:119,近期 85
逐年趋势
- 近年 SJR:2024 1.37(Q1) → 2025 1.97(Q1)
同学科期刊推荐
- The Lancet Respiratory Medicine — IF 34.7 · JCR Q1 · 中科院1区(Top)
- Intensive Care Medicine — IF 22.0 · JCR Q1 · 中科院1区(Top)
- American Journal of Respiratory and Critical Care Medicine — IF 21.7 · JCR Q1 · 中科院1区(Top)
- Critical Care — IF 11.4 · JCR Q1 · 中科院1区(Top)
- Chest — IF 9.8 · JCR Q1 · 中科院1区(Top)
- Critical Care Medicine — IF 7.5 · JCR Q1 · 中科院1区(Top)
- Journal of Intensive Care — IF 7.5 · JCR Q1 · 中科院2区
- Annals of Intensive Care — IF 6.9 · JCR Q1 · 中科院1区(Top)
常见问题
《Chinese Medical Journal - Pulmonary and Critical Care Medicine》的影响因子是多少?
根据 JCR 2025 年数据,《Chinese Medical Journal - Pulmonary and Critical Care Medicine》的最新影响因子(IF)为 7.900。
《Chinese Medical Journal - Pulmonary and Critical Care Medicine》是几区期刊?
《Chinese Medical Journal - Pulmonary and Critical Care Medicine》JCR 分区为 Q1。
本刊近期代表论文
- Asthma endotypes and theratypes (2026 · 被引 2)
- Burden of chronic respiratory diseases and their attributable risk factors in 204 countries and territories, 1990–2021: Results from the global burden of disease study 2021 (2025 · 被引 35)
- Global, regional, and national burden of asthma from 1990 to 2021: A systematic analysis of the global burden of disease study 2021 (2025 · 被引 34)
- Clinical management of checkpoint inhibitor pneumonitis: Focus, challenges, and future directions (2025 · 被引 13)
- Advances in pathophysiology and assessment methods of chronic obstructive pulmonary disease with frailty (2025 · 被引 8)
- Clinical characteristics of patients with positive fungal pathogens during acute exacerbation of chronic obstructive pulmonary disease: A retrospective study (2025 · 被引 6)